Table 3.

Maintenance rate of target Hb level^† (full analysis set)

	ESA‐Naïve group			ESA‐Converted group
Parameter	Roxadustat 50 mg (n = 6)	Roxadustat 70 mg (n = 7)	All ESA‐Naïve (n = 13)	All ESA‐Converted (n = 43)
Maintenance rate for all patients in the FAS
Maintenance rate, n (%)	5/6 (83.3)	7/7 (100.0)	12/13 (92.3)	32/43 (74.4)
95% CI, %	35.9–99.6	59.0–100.0	64.0–99.8	58.8–86.5
Maintenance rate for those patients in the FAS who had at least one Hb measurement between weeks 18 and 24
Maintenance rate, n (%)	5/6 (83.3)	7/7 (100.0)	12/13 (92.3)	32/37 (86.5)
95% CI, %	35.9–99.6	59.0–100.0	64.0–99.8	71.2–95.5

^†Target Hb level, 10.0–12.0 g/dL.

CI, confidence interval; ESA, erythropoiesis stimulating agent; FAS, full analysis set; Hb, hemoglobin.